Related Experiment Videos
Pathologic complete response of advanced ovarian mixed mesodermal tumor to cisplatin, adriamycin and dacarbazine: a
J Fanning1, S Zylstra, Y Tsukada
1Dept. of Gynecology Oncology, Roswell Park Memorial Institute, Buffalo.
European Journal of Gynaecological Oncology
|January 1, 1989
Abstract:
Presented is a case report of a stage IIIC primary ovarian mixed mesodermal tumor with gross residual disease following aggressive cytoreductive surgery. Following twelve courses of Cisplatin, Adriamycin and Dacarbazine, second-look laparotomy confirmed a pathologic complete response. The patient is now free of disease at 17+ months.